# First in Man Study of the JenaValve TAVI Plus System Transfemoral

> **NCT02818959** · NA · TERMINATED · sponsor: **JenaValve Technology, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Aortic Valve Stenosis
- Heart Valve Diseases
- Heart Diseases
- Cardiovascular Diseases

## Interventions

- **DEVICE:** JenaValve Pericardial TAVR System

## Key facts

- **NCT ID:** NCT02818959
- **Lead sponsor:** JenaValve Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2014-03
- **Final completion:** 2015-05
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Due to inability to recruit sufficient sample size in reasonable time frame.
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818959, "First in Man Study of the JenaValve TAVI Plus System Transfemoral". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02818959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*